4.6 Article

FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells

期刊

JOURNAL OF IMMUNOLOGY
卷 185, 期 12, 页码 7405-7412

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1002305

关键词

-

资金

  1. NCI NIH HHS [R21 CA131656, R21 CA131656-01A1] Funding Source: Medline
  2. NIAID NIH HHS [T32 AI007051, F31 AI077305, R01 AI067467-04, R01 AI067467] Funding Source: Medline

向作者/读者索取更多资源

FcR-like (FCRL) 2 is a transmembrane protein with immunomodulatory potential that is preferentially expressed by memory B cells in humans. It has two consensus ITIMs in addition to a putative ITAM sequence in its cytoplasmic domain. We have confirmed the cellular distribution of FCRL2 and analyzed its functional potential to show that coligation with the BCR leads to tyrosine phosphorylation of its ITIM motifs and subsequent Src homology region 2 domain-containing phosphatase-1 recruitment to facilitate inhibition of BCR signaling. Mutational analysis indicates that the tyrosine residues in both inhibitory motifs of FCRL2 are required for complete inhibition of BCR signaling, whereas tyrosines in the putative activation motif are dispensable for signal modulation. These findings suggest a negative immunomodulatory function for FCRL2 in the regulation of memory B cells. The Journal of Immunology, 2010, 185: 7405-7412.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据